|
1
|
Atlas Venture Life Science Advisors
Cambridge,
Massachusetts
|
$123M
|
–
|
–
|
–
|
|
|
2
|
|
$91M
|
+$19.4M
|
+413,611
|
+29%
|
|
|
3
|
Wellington Management Group
Boston,
Massachusetts
|
$90.4M
|
+$3.93M
|
+83,731
|
+5%
|
|
|
4
|
Bain Capital Life Sciences Investors
Boston,
Massachusetts
|
$88.2M
|
–
|
–
|
–
|
|
|
5
|
|
$87.7M
|
–
|
–
|
–
|
|
|
6
|
Frazier Life Sciences Management
Palo Alto,
California
|
$86.2M
|
–
|
–
|
–
|
|
|
7
|
Paradigm Biocapital Advisors
New York
|
$73.6M
|
-$56.7M
|
-1,206,998
|
-45%
|
|
|
8
|
T. Rowe Price Associates
Baltimore,
Maryland
|
$55.6M
|
+$458K
|
+9,753
|
+0.9%
|
|
|
9
|
Vanguard Group
Malvern,
Pennsylvania
|
$51.6M
|
-$2.91M
|
-61,894
|
-6%
|
|
|
10
|
Deerfield Management
New York
|
$50.3M
|
–
|
–
|
–
|
|
|
11
|
Logos Global Management
San Francisco,
California
|
$45.9M
|
+$469K
|
+10,000
|
+1%
|
|
|
12
|
State Street
Boston,
Massachusetts
|
$40.7M
|
+$11M
|
+235,115
|
+40%
|
|
|
13
|
Point72 Asset Management
Stamford,
Connecticut
|
$37.1M
|
-$261K
|
-5,562
|
-0.7%
|
|
|
14
|
Janus Henderson Group
London,
|
$36.8M
|
+$14.3M
|
+303,954
|
+68%
|
|
|
15
|
Adage Capital Partners
Boston,
Massachusetts
|
$27M
|
-$3.22M
|
-68,501
|
-11%
|
|
|
16
|
Saturn V Capital Management
Austin,
Texas
|
$25.1M
|
+$373K
|
+7,952
|
+2%
|
|
|
17
|
TCG Crossover Management
Palo Alto,
California
|
$23.9M
|
–
|
–
|
–
|
|
|
18
|
Geode Capital Management
Boston,
Massachusetts
|
$23.3M
|
+$3.33M
|
+70,983
|
+18%
|
|
|
19
|
Citadel Advisors
Miami,
Florida
|
$20.2M
|
+$4.2M
|
+89,503
|
+28%
|
|
|
20
|
Fidelity Investments
Boston,
Massachusetts
|
$20M
|
-$295K
|
-6,283
|
-2%
|
|
|
21
|
Perceptive Advisors
New York
|
$19M
|
-$7.81M
|
-166,420
|
-30%
|
|
|
22
|
Woodline Partners
San Francisco,
California
|
$18.5M
|
+$5.13M
|
+109,199
|
+41%
|
|
|
23
|
MPM BioImpact
Boston,
Massachusetts
|
$15.3M
|
+$287K
|
+6,103
|
+2%
|
|
|
24
|
Foresite Capital Management V
Larkspur,
California
|
$14.7M
|
–
|
–
|
–
|
|
|
25
|
Victory Capital Management
San Antonio,
Texas
|
$10.8M
|
-$4.32M
|
-92,035
|
-29%
|
|
